Innate Pharma Sa's ability to collect accounts receivable sequentially worsen to 87.92, indicating more challenging environment then in the third quarter 2025, but still, it is a far cry from any concerns. Innate Pharma Sa's Accounts Receivable average collection period in the Dec 31 2025 quarter, has increased to 4 days, from 3 days, in the 0 quarter.

If we take a look into Healthcare sector 469 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2025 from 0 to 3261.

What is Receivable Turnover Ratio?
What is Innate Pharma Sa Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

IPHA Receivables Turnover Ratio	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Receivable Change	-31.8 %	-	-	-	-96.01 %
Y / Y Revenue Change	-55.25 %	-	-	-	-67.36 %
Receivable Turnover Ratio (TTM)	87.92	133.98	133.98	133.98	133.98
IPHA's Total Ranking	# 3261	# 0	#	#	#
Accounts Receivable average collection period days	4	3	3	3	3
Seq. Receivable Change	-	-	-	-	-
Seq. Revenue Change	-	-	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 49
Healthcare Sector	# 470
Overall Market	# 3261

Receivable Turnover Ratio Statistics
High	Average	Low
0.33	0.21	0.09
(Dec 31 2023)		(Dec 31 2021)

IPHA Company Profile • Back to IPHA Efficiency Comparisons • Compare IPHA Receivables Turnover Ratio to its Competitors

Financial Statements
Innate Pharma Sa's Accounts Receivable	$ 0 Millions	Visit IPHA's Balance sheet
Innate Pharma Sa's Sales TTM	$ 10 Millions	Visit IPHA's Income Statement
Sources of IPHA's Revenues		Visit IPHA's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
IPHA's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
IPHA's Growth Rates	IPHA's Roa	IPHA's Inventory Turnover Ratio	IPHA's Dividend Comparisons
IPHA's Profitability Ratios	IPHA's Roi	IPHA's Asset Turnover Ratio	IPHA's Dividend Growth
IPHA's Valuation Ratios	IPHA's Roe	IPHA's Financial Strength Ratios	IPHA's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2025	Receivable at quarter ending Dec 31 2025
Crinetics Pharmaceuticals Inc	52.00	$ 7.696 Millions	$ 0.148 Millions
Galapagos Nv	51.75	$ 1,257.532 Millions	$ 24.301 Millions
Brookdale Senior Living Inc	51.27	$ 3,194.066 Millions	$ 62.298 Millions
Aim Immunotech Inc	50.29	$ 0.088 Millions	$ 0.002 Millions
Stoke Therapeutics Inc	48.58	$ 184.420 Millions	$ 3.796 Millions
Arvinas Inc	47.32	$ 262.600 Millions	$ 5.550 Millions
Eyepoint Inc	45.42	$ 31.371 Millions	$ 0.691 Millions
Vireo Growth Inc.	45.06	$ 268.769 Millions	$ 5.965 Millions
X4 Pharmaceuticals Inc	45.05	$ 35.113 Millions	$ 0.780 Millions
Fortrea Holdings Inc	44.55	$ 2,723.400 Millions	$ 61.125 Millions
Valion Bio Inc	42.84	$ 0.482 Millions	$ 0.011 Millions
Kyntra Bio Inc	41.55	$ 6.440 Millions	$ 0.155 Millions
Cytomx Therapeutics Inc	40.82	$ 76.201 Millions	$ 1.867 Millions
Atara Biotherapeutics Inc	40.31	$ 121.355 Millions	$ 3.010 Millions
Nature s Sunshine Products inc	39.85	$ 479.724 Millions	$ 12.040 Millions
National Vision Holdings Inc	39.24	$ 1,987.488 Millions	$ 50.646 Millions
Lineage Cell Therapeutics Inc	39.16	$ 14.556 Millions	$ 0.372 Millions
Meiragtx Holdings Plc	36.74	$ 81.391 Millions	$ 2.215 Millions
Marpai Inc	36.38	$ 18.099 Millions	$ 0.497 Millions
Premier Air Charter Holdings Inc	34.28	$ 31.878 Millions	$ 0.930 Millions
Metagenomi Therapeutics Inc	32.01	$ 25.210 Millions	$ 0.788 Millions
U S Physical Therapy Inc	30.83	$ 780.990 Millions	$ 25.331 Millions
Prenetics Global Limited	30.82	$ 91.790 Millions	$ 2.978 Millions
Invo Fertility Inc	30.16	$ 6.841 Millions	$ 0.227 Millions
Innovative Eyewear Inc	28.53	$ 2.662 Millions	$ 0.093 Millions
Newgenivf Group Limited	28.38	$ 4.726 Millions	$ 0.167 Millions
Electrocore Inc	26.63	$ 31.800 Millions	$ 1.194 Millions
Innovage Holding Corp	26.09	$ 915.371 Millions	$ 35.080 Millions
Polomar Health Services, Inc.	25.80	$ 0.648 Millions	$ 0.025 Millions
Keros Therapeutics Inc	25.67	$ 257.786 Millions	$ 10.042 Millions

Date modified: 2026-09-18T13:11:06+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.